Get started
EPIGENOMICS AG NPV (POST CONVERSION)EPIGENOMICS AG NPV (POST CONVERSION)EPIGENOMICS AG NPV (POST CONVERSION)

EPIGENOMICS AG NPV (POST CONVERSION)

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

0QXH chart


Full chart

Key stats


Market capitalization
‪771.72 K‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.8242 EUR
Net income (FY)
‪−3.35 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪745.44 K‬
Beta (1Y)
0.89

About EPIGENOMICS AG NA O.N.


Sector
Health Technology
Industry
Medical Specialties
Website
epigenomics.com
Headquarters
Heidelberg
Founded
2000
ISIN
DE000A37FT41
FIGI
BBG00NRVY3M3
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.

Check out other big names from the same industry as 0QXH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0QXH is 0.8900 EUR — it has decreased by −12.75% in the past 24 hours. Watch EPIGENOMICS AG NPV (POST CONVERSION) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange EPIGENOMICS AG NPV (POST CONVERSION) stocks are traded under the ticker 0QXH.
0QXH reached its all-time high on Aug 18, 2020 with the price of 496.4899 EUR, and its all-time low was 0.8900 EUR and was reached on Jun 13, 2025. View more price dynamics on 0QXH chart.
See other stocks reaching their highest and lowest prices.
0QXH stock is 14.61% volatile and has beta coefficient of 0.89. Track EPIGENOMICS AG NPV (POST CONVERSION) stock price on the chart and check out the list of the most volatile stocks — is EPIGENOMICS AG NPV (POST CONVERSION) there?
Yes, you can track EPIGENOMICS AG NPV (POST CONVERSION) financials in yearly and quarterly reports right on TradingView.
0QXH net income for the last half-year is ‪−2.56 M‬ EUR, while the previous report showed ‪−796.00 K‬ EUR of net income which accounts for −221.11% change. Track more EPIGENOMICS AG NPV (POST CONVERSION) financial stats to get the full picture.
No, 0QXH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0QXH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPIGENOMICS AG NPV (POST CONVERSION) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EPIGENOMICS AG NPV (POST CONVERSION) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EPIGENOMICS AG NPV (POST CONVERSION) stock shows the sell signal. See more of EPIGENOMICS AG NPV (POST CONVERSION) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.